Skip to content
DefDex

Federal award

ORTHO-CLINICAL DIAGNOSTICS SINGAPORE PTE. LTD. KOREA BRANCH

W81K0223P0026

Contract

Obligated and Ceiling

Obligated (net)
$1,997,676.24
Ceiling (potential value, not spending)
$2,662,461.24
Current value
$1,997,676.24
Gross positive obligations
$2,107,061.49

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
ORTHO-CLINICAL DIAGNOSTICS SINGAPORE PTE. LTD. KOREA BRANCH · JNSJRDQQH2J6
Awarding agency
Department of War · sub-agency 97DH · office HT9410
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0223P0026
Award type code
B
Actions
12 · Feb 9, 2023 to May 7, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History12

Award actions
DateFYModAction typeObligationCompany in company totals
May 7, 2026FY2026P00011M$0.00
—
Apr 7, 2026FY2026P00010M$0.00
—
Dec 10, 2025FY2026P00009C$664,785.00
—
Aug 12, 2025FY2025P00008G$0.00
—
Dec 17, 2024FY2025P00007B$0.00
—
Oct 22, 2024FY2025P00006C$664,785.00
—
May 30, 2024FY2024P00005G$0.00
—
Feb 27, 2024FY2024P00004B$84,718.20
—
Jan 17, 2024FY2024P00003B−$109,385.25
—
Oct 20, 2023FY2024P00002C$583,388.04
—
Aug 9, 2023FY2023P00001G$0.00
—
Feb 9, 2023FY20230—$109,385.25
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.